Summary
Quinnova Pharmaceuticals, Inc., a specialty dermatological pharmaceutical company focused onthe development and commercial sale of prescription drug products based on innovative dermal drug delivery platforms, announcedtoday that it has completed a $13.6 million Series A round of private financing. Participating in the financing are Thomas, McNerney &Partners, H.I.G. Ventures and an investor syndicate led by Omnivest (Bermuda) Ltd.
Click Here
to read the full article
Click Here
to read the full article
